期刊文献+

血管紧张素Ⅱ受体拮抗剂对高血压病患者血尿酸影响的研究 被引量:1

The effect of angiotens Ⅱ receptor antagonist on serum uric acid among the hypertensive patients
下载PDF
导出
摘要 目的 探讨血管紧张素Ⅱ受体拮抗剂氯沙坦 (Losartan)对高血压病患者血尿酸的影响。方法 采用前瞻性分析研究 ,将 6 0例高血压病患者随机分为两组 ,每组 30例。Losartan组 :给予Losartan 5 0mgqd ;西拉普利 (Cilazapril)组 ,给予Cilazapril2 5mgqd ;疗程 4周 ,观察治疗前后血尿酸的变化。结果 与基础值相比 ,Losartan组血尿酸明显降低 ,P <0 0 1,西拉普利组血尿酸轻度降低 ,但无统计学差异。结论 Losartan治疗高血压在降压同时具有降低血尿酸的作用。 Objective To observe the effect of angiorensin Ⅱ receptor antagonist on serum uric acid among the hypertensive patients.Methods 60 hypertensive patients were randomly divided into two groups.Losartan group(30 cases),Losartan 50mg qd;Cilazapril group(30 cases),Cliazapril 2.5mg qd.The course of treatment was four weeks.Serum uric acid was measured before and after treatment.Results Compareal with the besical value,serum uric acid decreased significantly(P<0.01) in Losartan group,but not in Cilazapril group(P>0.05).Conclusion Losartan can not only decrease the blood pressure but also subdue serum uric acid in hypertensive patients.
出处 《临床中老年保健》 2002年第2期96-97,共2页
关键词 血管紧张素Ⅱ受体拮抗剂 高血压病 血尿酸 影响 氯沙坦 Hypertensive disaease Serum uric acid Losartan
  • 相关文献

参考文献5

  • 1[1]Ward HJ. Uric acid as independent risk factor in the treatment of hypertension. Lancet, 1998,352: 670
  • 2[2]Casiglia E, Spolaore P, Ginocchiio G, et a. Predictors of mortality in very old subject aged 80 years or over. Eur J Epidemiol, 1993,9: 577
  • 3[3]Johnson R J, Schrciner GF. Hypothesis: the role of acquired tubulointerstitial disease in the pathopenesis of salt-dependents hypertension. Kidney Int, 1997,52:1169
  • 4[4]Burnier M,Brunner HR. Renal effect of angiotension Ⅱ receptor blockade and angiotension-converting enzyme inhibition in he alt hy subjects. Exp Nephrol, 1996,4: 41
  • 5[5]Csajka C, Bvclin T, Brunner HR, et al. Pharmacokineticpharmacodynamic profile of angiotensin Ⅱ receptor antagonists. Clin Pbarma-cokinet, 1997,32:1

同被引文献18

  • 1Indada Y,Wada T,Ojima M,et al.Protective effects of candesartan dlexetil(TCV-116) against stroke,kidney dysfunction and cardiac hypertrophy in stroke-prone pontaneously hypertensive rats[J].Clin Exp Hpertens,1997,19:1 079~1 099.
  • 2Hauser A C,Horl W H.AngiotensionⅡ typer-1-receptor antagonists from the view point of nephrology[J].Wien Med Wocbenschr,2001,151(7~8):160~164.
  • 3Siragy H M,Inagami T,Ichiki T,et al.Sustained hypersensitivity to angiotensin Ⅱ and its mechanism in mice lacking the subtype-2(AT2) angiotensin receptor[J].Proc Natl Acad Sci USA,1999,96:6 506~6 510.
  • 4Oparil S.Newly emerging phamacologic differences in angiotensin Ⅱ receptor blockers[J].Am J Hypertens,2000,13(1p62):18~24.
  • 5Birkenhager W H,del-leeuw P W.Non-pep-tide angiotensin typeⅡ receptor antagonists in the treatment to hypertension[J].Hpertension,1999,17(7):873~881.
  • 6Kumagai H,Sakata K,Matsuura T,et al.Comparison of ARB and ACEI for renoprotection in chronic glomerulonephritis[J].Nippon Rinsho,2002,60(10):2 005~2 013.
  • 7Otsm,Mackenzie H S,Tory J L,et al.Renoprotective and anti hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic(mRen-2) 27 rat[J].Nephrol Dial Transplant,2001,16(7):1 343~1 349.
  • 8Lacoureiere Y,Belanger A,Godin C,et al.Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetis with early nephropathy[J].Kidney Int,2000,58:764~770.
  • 9Feig D land R J.Johnson Hyperuricemia in Childhood Primary Hypertension[J].Hypertension,2003,42:247~252.
  • 10Watanabe S,Kang D H,Feng L,et al.Uric acid,hominoid evolution,and the pathogenesis Salt-sensitivity[J].Hypertension,2002,40:355~360.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部